#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-myelin-associated glycoprotein associated polyneuropathy Biliary cancer metastatic Malignant central nervous system neoplasm Cholangiosarcoma Extranodal marginal zone B-cell lymphoma (MALT type) Angiosarcoma metastatic Thromboangiitis obliterans Malignant melanoma Malignant peritoneal neoplasm Lip and/or oral cavity cancer Gastrointestinal cancer metastatic IPEX syndrome Haemolytic uraemic syndrome Glomerulonephritis minimal lesion B-cell type acute leukaemia More trials…

    Learn about Rare Diseases

    Fabry’s disease – Trials in Disease Tuberous sclerosis complex – Trials in Disease Cystic fibrosis lung – Treatment CADASIL – Life with Disease Rhabdomyosarcoma Myelodysplastic syndrome with excess blasts – Life with Disease Hereditary motor and sensory neuropathy – Trials in Disease MELAS syndrome Angelman’s syndrome Mucous membrane pemphigoid – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Df6002 Asparaginase Flutafuranol (18F) Valsartan Trifluridine Codeine Phosphate Ribonucleic Acid Amifostine Thiol Nystatin Odm-111 Warfarin Mk-4830 Azd3470 Eclitasertib Art0380 Mesilate Amlodipine Verapamil Hydrochloride Ceralasertib Asp1570 Omo-103 More therapies…

    Learn about Your Condition

    Desmoid tumour Extra-osseous Ewing's sarcoma Brain neoplasm Transferrin decreased Genital infection female Non-obstructive cardiomyopathy Metastatic glioma Stress urinary incontinence Scoliosis Endotracheal intubation Adenosquamous cell lung cancer Cardiomyopathy Conjunctivitis allergic Oral herpes Paresis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Krankenhaus Nordwest GmbH

Krankenhaus Nordwest GmbH

Steinbacher Hohl 2-26, Praunheim, Frankfurt, 60488, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    Belgium Czechia France Germany Italy Lithuania +5

  • Study of AZD4360 safety and effectiveness in adults with advanced solid tumors including gastric, gastroesophageal junction, biliary tract cancer and pancreatic cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    • Biliary neoplasm
    • Gastric cancer
    Investigated Drugs:
    • AZD4360
    Germany

  • A study of futibatinib combined with tislelizumab, fluorouracil, calcium folinate, and oxaliplatin as first-line treatment for patients with colorectal cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Fluorouracil
    • Futibatinib
    Germany

  • Study of M9140 for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Austria France Germany Italy Spain

  • Study of M9140 for Patients with Advanced Stomach Cancer

    Not recruiting

    1 1 1
    Austria France Germany Italy Spain

  • Study on the Safety and Effectiveness of Trastuzumab Deruxtecan and Drug Combination for Patients with HER2-Positive Gastric, GEJ, and Esophageal Cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Durvalumab
    Germany Italy The Netherlands Poland Spain

  • Study on ABBV-400, Fluorouracil, Leucovorin, and Budigalimab for Advanced or Metastatic Stomach and Esophageal Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Budigalimab
    • Fluorouracil
    • Folinic Acid
    Belgium Germany Spain

  • Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Eftilagimod Alfa
    Austria Belgium Bulgaria Croatia Germany Greece +9

  • Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    • Quemliclustat
    Austria Belgium Czechia France Germany Italy +3

  • Study on ANV600 and Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Anv600
    • Pembrolizumab
    Belgium France Germany The Netherlands Spain
Previous Page
1 … 7 8 9 10 11 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!